Skip to main content
. 2016 Dec 2;8(2):3396–3411. doi: 10.18632/oncotarget.13773

Figure 1. GSK126 inhibits cellular EZH2 methyltransferase activity in multiple myeloma (MM) cells.

Figure 1

A. Chemical structure of GSK126. B. MM.1S and LP1 cells were treated with increasing concentrations of GSK126 for 72 h, the whole cell lysates were subjected to immunoblotting for analysis of EZH2, H3K27me3, H3K4me3 and H3.